The administration of linagliptin for 8 consecutive days before morphine injection, however, significantly diminished the number of naloxone-induced jumping behaviors on the 9th day of the study, thus, indicating the involvement of the GLP-1 peptide in the attenuation of physical symptoms of morphine dependence. This evidence concerns the gene GCG and morphine dependence.